(Q34465775)

2 August 2017

1 reference

title

Psychosis and behavioural symptoms of dementia: defining the role of neuroleptic interventions (English)

1 reference

2 August 2017

1 reference

1 reference

Lawlor B

1

1 reference

2 August 2017

Bhriain SN

series ordinal

2

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 December 2001

1 reference

International Journal of Geriatric Psychiatry

2 August 2017

published in

1 reference

2 August 2017

volume

16 Suppl 1

1 reference

2 August 2017

page(s)

S2-6

1 reference

Relationship of aggressive behavior to other neuropsychiatric symptoms in patients with Alzheimer's disease.

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1099-1166%28200112%2916%3A1%2B%3C%3A%3AAID-GPS567%3E3.0.CO%3B2-P

A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1166%28200112%2916%3A1%2B%3C%3A%3AAID-GPS567%3E3.0.CO%3B2-P

Symptoms of mental impairment among elderly adults and their effects on family caregivers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1166%28200112%2916%3A1%2B%3C%3A%3AAID-GPS567%3E3.0.CO%3B2-P

A randomized, placebo-controlled dose-comparison trial of haloperidol for psychosis and disruptive behaviors in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1166%28200112%2916%3A1%2B%3C%3A%3AAID-GPS567%3E3.0.CO%3B2-P

Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1166%28200112%2916%3A1%2B%3C%3A%3AAID-GPS567%3E3.0.CO%3B2-P

[The clinical picture and stability of non-cognitive symptoms in patients with Alzheimer's disease]

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1166%28200112%2916%3A1%2B%3C%3A%3AAID-GPS567%3E3.0.CO%3B2-P

A 2-year follow-up of behavioural and psychological symptoms in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1166%28200112%2916%3A1%2B%3C%3A%3AAID-GPS567%3E3.0.CO%3B2-P

Natural history of behavioural changes and psychiatric symptoms in Alzheimer's disease. A longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1166%28200112%2916%3A1%2B%3C%3A%3AAID-GPS567%3E3.0.CO%3B2-P

Behaviour changes in dementia. 2: Are there behavioural syndromes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1166%28200112%2916%3A1%2B%3C%3A%3AAID-GPS567%3E3.0.CO%3B2-P

Lower incidence of tardive dyskinesia with risperidone compared with haloperidol in older patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1166%28200112%2916%3A1%2B%3C%3A%3AAID-GPS567%3E3.0.CO%3B2-P

Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1166%28200112%2916%3A1%2B%3C%3A%3AAID-GPS567%3E3.0.CO%3B2-P

Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1166%28200112%2916%3A1%2B%3C%3A%3AAID-GPS567%3E3.0.CO%3B2-P

Behavior Rating Scale for Dementia: development of test scales and presentation of data for 555 individuals with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1166%28200112%2916%3A1%2B%3C%3A%3AAID-GPS567%3E3.0.CO%3B2-P

Rivastigmine in the treatment of dementia with Lewy bodies: preliminary findings from an open trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1166%28200112%2916%3A1%2B%3C%3A%3AAID-GPS567%3E3.0.CO%3B2-P

Do neuroleptic drugs hasten cognitive decline in dementia? Prospective study with necropsy follow up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1166%28200112%2916%3A1%2B%3C%3A%3AAID-GPS567%3E3.0.CO%3B2-P

Incontinence and troublesome behaviors predict institutionalization in dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1166%28200112%2916%3A1%2B%3C%3A%3AAID-GPS567%3E3.0.CO%3B2-P

Better cognitive and psychopathologic response to donepezil in patients prospectively diagnosed as dementia with Lewy bodies: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1166%28200112%2916%3A1%2B%3C%3A%3AAID-GPS567%3E3.0.CO%3B2-P

A metaanalysis of controlled trials of neuroleptic treatment in dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1166%28200112%2916%3A1%2B%3C%3A%3AAID-GPS567%3E3.0.CO%3B2-P

Assessment of cognitive, psychiatric, and behavioral disturbances in patients with dementia: the Neurobehavioral Rating Scale.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1166%28200112%2916%3A1%2B%3C%3A%3AAID-GPS567%3E3.0.CO%3B2-P

Behavioral Syndromes in Alzheimer’s Disease: Description and Correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1166%28200112%2916%3A1%2B%3C%3A%3AAID-GPS567%3E3.0.CO%3B2-P

Behavioral disturbances and pharmacological treatment of patients with dementia in family caregiving: a 2-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1166%28200112%2916%3A1%2B%3C%3A%3AAID-GPS567%3E3.0.CO%3B2-P

Efficacy and safety of neuroleptics in behavioral disorders associated with dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1166%28200112%2916%3A1%2B%3C%3A%3AAID-GPS567%3E3.0.CO%3B2-P

Prevalence and pharmacological management of behavioural and psychological symptoms amongst dementia sufferers living in care environments

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1166%28200112%2916%3A1%2B%3C%3A%3AAID-GPS567%3E3.0.CO%3B2-P

Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial. The HGEU Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1099-1166%28200112%2916%3A1%2B%3C%3A%3AAID-GPS567%3E3.0.CO%3B2-P

10.1002/1099-1166(200112)16:1+<::AID-GPS567>3.0.CO;2-P

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference